Ítalo Rosal Lustosa

Dr. Ítalo Rosal Lustosa

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
PAPedro Everson Alexandre de Aquino
Pedro Everson Alexandre de Aquino
Jéssica Rabelo BezerraJéssica Rabelo Bezerra
Jéssica Rabelo Bezerra
TNTyciane de Souza Nascimento
Tyciane de Souza Nascimento
JTJuliete Tavares
Juliete Tavares
Ítalo Rosal LustosaÍtalo Rosal Lustosa
Ítalo Rosal Lustosa
GVGLAUCE VIANA
GLAUCE VIANA
The N-methyl-(2S,4R)-trans-4-hydroxy-l-proline-enriched fraction (NMP) from Sideroxylon obtusifolium was evaluated as a neuroprotective agent in the intracerebroventricular (icv) pilocarpine (Pilo) model. To this aim, male mice were subdivided into sham (SO, vehicle), Pilo (300 µg/1 µL icv, followed by the vehicle per os, po) and NMP-treated groups (Pilo 300 µg/1 µL icv, followed by 100 or 200 mg/kg po). The treatments started one day after the Pilo injection and continued for 15 days. The effects of NMP were assessed by characterizing the preservation of cognitive function in both the Y-maze and object recognition tests. The hippocampal cell viability was evaluated by Nissl staining. Additional markers of damage were studied—the glial fibrillary acidic protein (GFAP) and the ionized calcium-binding adaptor molecule 1 (Iba-1) expression using, respectively, immunofluorescence and western blot analyses. We also performed molecular docking experiments revealing that NMP binds to the γ-aminobutyric acid (GABA) transporter 1 (GAT1). GAT1 expression in the hippocampus was also characterized. Pilo induced cognitive deficits, cell damage, increased GFAP, Iba-1, and GAT1 expression in the hippocampus. These alterations were prevented, especially by the higher NMP dose. These data highlight NMP as a promising candidate for the protection of the hippocampus, as shown by the icv Pilo model.

23 May 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
PAPedro Everson Alexandre de Aquino
Pedro Everson Alexandre de Aquino
JGJosimar Girão
Josimar Girão
TNTyciane de Souza Nascimento
Tyciane de Souza Nascimento
Ítalo Rosal LustosaÍtalo Rosal Lustosa
Ítalo Rosal Lustosa
GAGeanne Matos Andrade
Geanne Matos Andrade
GVGLAUCE VIANA
GLAUCE VIANA
Background/Objectives: The main biologically active molecules of Cannabis sativa L. are cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC). Both exert anticonvulsant effects when evaluated as single drugs, but their possible interaction as components of C. sativa extracts has been scarcely studied. For this reason, we evaluated CBD and THC, combined or not, in two seizure models in mice, using an improved vehicle formula. Methods: Firstly, acute seizures were induced by intraperitoneal (i.p.) pentylenetetrazole (PTZ, 80 mg/kg), and mice received CBD or THC at 1, 3, 6, and 10 mg/kg, or a CBD/THC 1:1 combination at 1.5, 3, and 6 mg/kg, per os (p.o.), one hour before PTZ administration. Secondly, mice received p.o. CBD (10 mg/kg), CBD/THC (1.5, 3, and 6 mg/kg), valproic acid (50 mg/kg), or vehicle (nanoemulsions without CBD or THC), one hour before PTZ (30 mg/kg, i.p.) every other day for 21 days. Behavioral, biochemical, and immunohistochemical analyses were performed to assess the response to PTZ, oxidative stress, and astroglial activation. Results: In the acute model, CBD and THC at 3–10 mg/kg, and their combinations, significantly increased latency to generalized seizures and death, and improved survival rates. In the chronic model, similarly to valproic acid, CBD 10 mg/kg and CBD/THC at 1.5 and 3 mg/kg delayed kindling acquisition, while CBD/THC 6 mg/kg had no effect. CBD and CBD/THC treatments reduced oxidative and nitrosative stress and attenuated astrogliosis, as indicated by decreased glial fibrillary acidic protein and GABA transporter 1 expression and increased inwardly rectifying potassium channel 4.1 expression in hippocampal regions. However, no cannabinoid treatment prevented the impairment in novel object recognition and Y maze tests. Conclusions: These findings support the potential role of cannabinoids in counteracting seizures, possibly by reducing oxidative stress and astrogliosis. The study also highlights the importance of nanoemulsions as a delivery vehicle to enhance cannabinoid effectiveness while considering the risks associated with direct cannabinoid receptor activation.

9 March 2015 in Semina: Ciências Biológicas e da Saúde
Verified
Journal Article
Open access
PDF file
NLNara Nyely Noronha Luz
Nara Nyely Noronha Luz
Ítalo Rosal LustosaÍtalo Rosal Lustosa
Ítalo Rosal Lustosa
KMKátia da Conceição Machado
Kátia da Conceição Machado
APAna Carolina Landim Pacheco
Ana Carolina Landim Pacheco
APAna Paula Peron
Ana Paula Peron
PFPaulo Michel Pinheiro Ferreira
Paulo Michel Pinheiro Ferreira
Este trabalho avaliou o conhecimento dos alunos do Curso de Ciências Biológicas da Universidade Federal do Piauí, Campus Senador Helvídio Nunes de Barros sobre o Papilomavírus Humano (HPV). A maioria dos estudantes universitários (n=218) eram do sexo feminino (78%), com idade entre 17 e 34 anos (60%), onde 84% eram solteiros e com renda familiar entre 2-5 salários mínimos (64%). A partir dos resultados, verificou-se que 87% conhecem o HPV, 83% o consideram como uma DST, 68% acreditam que tanto o homem quanto a mulher pode transmitir e se infectar pelo HPV, 48% acreditam na possibilidade de transmissão vertical, 35% consideram que o HPV possa infectar genitálias, cabeça e pescoço, 60% dos universitários responderam que o exame laboratorial utilizado para a prevenção e detecção inicial da infecção é o Papanicolau. Em relação aos fatores de risco, 64% afirmaram ter vida sexual ativa, 50% iniciaram sua vida sexual entre 13 e 17 anos, 44% usam preservativo durante relações sexuais, 63% consomem bebidas alcoólicas e 94% não fumam. A maioria afirmou (64%) não existir vacina contra o HPV, 52% acreditam em uma relação entre o HPV e o câncer de colo uterino e 97% gostariam de ler mais informações sobre o HPV. Assim, verificou-se que os alunos universitários revelaram conhecimento primário sobre o HPV e sobre formas de prevenção da doença. No entanto, quase a metade dos entrevistados desconhece a gravidade da infecção ocasionada por HPV como causa elementar para o surgimento de cânceres de colo uterino.

4 November 2022 in Brazilian Journal of Medical and Biological Research
Verified
Journal Article
Open access
PAP.E.A. Aquino
P.E.A. Aquino
ESE.A. de Siqueira
E.A. de Siqueira
LPL.C.F. Paes
L.C.F. Paes
EME.P. Magalhães
E.P. Magalhães
TBT.M. Barbosa
T.M. Barbosa
GVGLAUCE VIANA
GLAUCE VIANA
Glial cells have been implicated in temporal lobe epilepsy in humans and in its models. Astrocytes are lost in several brain regions after acute seizures induced by pilocarpine and may suffer hyperplasia at subsequent time points. This study investigated the effect of N-methyl-(2S,4R)-trans-4-hydroxy-L-proline (NMP) on astrocytes exposed to cytotoxic concentrations of pilocarpine. Astrocytes were incubated with pilocarpine (half maximal inhibitory concentration (IC50)=31.86 mM) for 24 h. Afterwards, they were treated with NMP at concentrations ranging from 3.12 to 100 μg/mL for 24 h. Cell viability was assessed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Cytoplasmic reactive oxygen species (ROS) and mitochondrial transmembrane potential (ΔΨm) were analyzed by flow cytometry using 2',7'-dichlorofluorescein diacetate (DCFH-DA) and rhodamine-123 (Rho123), respectively. Expression of glial fibrillary acidic protein (GFAP) and voltage-dependent anion channel-1 (VDAC-1) were measured by western blot. Pilocarpine significantly decreased cell viability and mitochondrial potential and increased ROS concentration significantly by 6.7 times compared to the control. NMP concentrations ≥25 µg/mL protected astrocytes against pilocarpine-induced injury in a concentration-dependent manner. Concomitantly, NMP reduced cytoplasmic ROS accumulation to 27.3, 24.8, and 12.3% in the groups treated with 25, 50, and 100 µg/mL NMP, respectively. NMP also protected mitochondria from pilocarpine-induced depolarization. These effects were associated with improvement of pilocarpine-induced GFAP and VDAC-1 overexpression, which are important biomarkers of astrocyte dysfunction. In conclusion, the improvement of ROS accumulation, VDAC-1 overexpression, and mitochondrial depolarization are possible mechanisms of the NMP protective action on reactive astrocytes.

Verified
Journal Article
Open access
PDF file
Ítalo Rosal LustosaÍtalo Rosal Lustosa
Ítalo Rosal Lustosa
JSJoana I. Soares
Joana I. Soares
Giuseppe BiaginiGiuseppe Biagini
Giuseppe Biagini
NLNikolay Lukoyanov
Nikolay Lukoyanov
The amygdala is a cerebral region whose function is compromised in temporal lobe epilepsy (TLE). Patients with TLE present cognitive and emotional dysfunctions, of which impairments in recognizing facial expressions have been clearly attributed to amygdala damage. However, damage to the amygdala has been scarcely addressed, with the majority of studies focusing on the hippocampus. The aim of this study was to evaluate epilepsy-related plasticity of cholinergic projections to the basolateral nucleus (BL) of the amygdala. Adult rats received kainic acid (KA) injections and developed status epilepticus. Weeks later, they showed spontaneous recurrent seizures documented by behavioral observations. Changes in cholinergic innervation of the BL were investigated by using an antibody against the vesicular acetylcholine transporter (VAChT). In KA-treated rats, it was found that (i) the BL shrunk to 25% of its original size (p < 0.01 vs. controls, Student’s t-test), (ii) the density of vesicular acetylcholine transporter-immunoreactive (VAChT-IR) varicosities was unchanged, (iii) the volumes of VAChT-IR cell bodies projecting to the BL from the horizontal limb of the diagonal band of Broca, ventral pallidum, and subcommissural part of the substantia innominata were significantly increased (p < 0.05, Bonferroni correction). These results illustrate significant changes in the basal forebrain cholinergic cells projecting to the BL in the presence of spontaneous recurrent seizures.

4 April 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
PAPedro Everson Alexandre de Aquino
Pedro Everson Alexandre de Aquino
JGJosimar Girão
Josimar Girão
TNTyciane de Souza Nascimento
Tyciane de Souza Nascimento
Ítalo Rosal LustosaÍtalo Rosal Lustosa
Ítalo Rosal Lustosa
GAGeanne Matos Andrade
Geanne Matos Andrade
ESEdilberto Silveira
Edilberto Silveira
The interaction between cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) in exerting anticonvulsant effects has been scarcely studied. To improve this knowledge, we evaluated CBD and THC, combined or not, in two seizure models in mice, using an improved vehicle formula. Firstly, acute seizures were induced by intraperitoneal (i.p.) pentylenetetrazole (PTZ, 80 mg/kg), and mice received CBD or THC at 1, 3, 6, and 10 mg/kg, or a CBD/THC 1:1 combination at 1.5, 3, and 6 mg/kg, per os (p.o.), one hour before PTZ administration. Secondly, mice received p.o. CBD (10 mg/kg), CBD/THC (1.5, 3, and 6 mg/kg), valproic acid (50 mg/kg), or vehicle, one hour before PTZ (30 mg/kg, i.p.) every other day for 21 days. Behavioral, biochemical, and immunohistochemical analyses were performed to assess the response to PTZ, oxidative stress, and astroglial activation. In the acute model, CBD and THC at 3-10 mg/kg, and their combinations, significantly increased latency to generalized seizures and death, and improved survival rates. In the chronic model, similarly to valproic acid, CBD 10 mg/kg and CBD/THC at 1.5 and 3 mg/kg delayed kindling acquisition, while CBD/THC 6 mg/kg had no effect. CBD and CBD/THC treatments reduced oxidative and nitrosative stress and attenuated astrogliosis, as indicated by decreased glial fibrillary acidic protein and GABA transporter 1 expression, and increased inwardly rectifying potassium channel 4.1 expression in hippocampal regions. However, no cannabinoid treatment prevented the impairment in novel object recognition and Y maze tests. These findings support the potential role of cannabinoids in counteracting seizures, possibly by reducing oxidative stress and astrogliosis. The study also highlights the importance of nanoemulsions as a delivery vehicle to enhance cannabinoid effectiveness while considering the risks associated with direct cannabinoid receptor activation.